Home NDC 69097-855 naproxen
Product NDC 69097-855
11-digit product format 690970855
Labeler code 69097
Product ID 69097-855_598c64ad-f0c4-495e-b2c2-cde215d2572d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name naproxen
Dosage form TABLET
Route ORAL
Labeler Cipla USA Inc.
Application ANDA091305
Marketing category ANDA
Marketing start 2016-07-05
Substance NAPROXEN
Active strength 500 mg/1
Pharmacologic classes Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A091305-001 NAPROXEN NAPROXEN 250MG TABLET / ORAL 2011-08-24 A091305-002 NAPROXEN NAPROXEN 375MG TABLET / ORAL 2011-08-24 A091305-003 NAPROXEN NAPROXEN 500MG TABLET / ORAL 2011-08-24
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 8072bd15b7f6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 78 observed states.
Additional Listing Data#
Finished product Yes
Brand name base naproxen
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength NAPROXEN 500 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 57Y76R9ATQ Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 198012 Internal RxNorm lookup 198013 Internal RxNorm lookup 198014 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 69097-855-07 naproxen 100 in 1 BOTTLE TABLET 100 5 69097-855-12 naproxen 500 in 1 BOTTLE TABLET 500 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 69097-855 NAPROXEN TABLET [CIPLA USA INC.] 5 Current NDC, Legacy NDC, 2 package rows 20230119_a9549a47-3fa4-4a2b-95ac-b00e43aedae7.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join naproxen NAPROXEN Cipla USA Inc. a9549a47-3fa4-4a2b-95ac-b00e43aedae7 2023-01-18 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 091305 application number: ANDA091305 ndc (product): 69097-855 Naproxen NAPROXEN Exelan Pharmaceuticals, Inc. 46dbdb95-a0d0-4410-8d64-b22763b12af7 2020-08-17 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 091305 application number: ANDA091305 Naproxen NAPROXEN Aphena Pharma Solutions - Tennessee, LLC e2347581-90da-429a-b17c-cffd0039fb86 2017-10-23 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 091305 application number: ANDA091305
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 69097-855-07 69097085507 100 TABLET in 1 BOTTLE (69097-855-07) 100 tablet 2016-07-05 0000-00-00 No No Current 69097-855-12 69097085512 500 TABLET in 1 BOTTLE (69097-855-12) 500 tablet 2016-07-05 0000-00-00 No No Current